Recent progress in mRNA cancer vaccines
The research and development of messenger RNA (mRNA) cancer vaccines have gradually overcome numerous challenges through the application of personalized cancer antigens, structural optimization of mRNA, and the development of alternative RNA-based vectors and efficient targeted delivery vectors. Cli...
Saved in:
| Main Authors: | Ruhui Yao, Chunyuan Xie, Xiaojun Xia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2307187 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mRNA vaccines in the context of cancer treatment: from concept to application
by: Qiang Fu, et al.
Published: (2025-01-01) -
mRNA vaccine designs for optimal adjuvanticity and delivery
by: Yuki Mochida, et al.
Published: (2024-12-01) -
Novel Bivalent mRNA‐LNP Vaccine for Highly Effective Protection against Pneumonic Plague
by: Uri Elia, et al.
Published: (2025-07-01) -
Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity
by: Zhen Xu, et al.
Published: (2024-12-01) -
Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01)